06-Nov-15 Korea's Hanmi Pharmaceutical has signed a contract with Sanofi to export USD4 bn worth of diabetes treatment technology, in a deal worth almost 30% of the value of the entire Korean pharma industry. Sanofi gains an exclusive worldwide license to develop and commercialize drugs based on the materials, except in Korea and China, where Hanmi retains co-commercialization rights. [image: Business Korea]

05-Nov-15 Korea's Fair Trade Commission has launched an investigation of Siemens Korea’s alleged unfair business practices in the field of medical equipment. According to the FTC, Siemens has refused to provide MRI and CT equipment software ownership and provided only the right to use the software.

19-Oct-15 Korea's "Third Basic Plan on Low Fertility and Aging Society” is intended to raise the country’s fertility rate from 1.2 to 1.5 by 2020. The plan includes housing assistance measures for the younger generation and the newly married. Medical expenses relating to pregnancy are to be reduced, and medical procedures for fertility are to be covered by national health insurance. [image: Business Korea]

15-Oct-15 Vetter, a global leader in aseptic manufacturing of drug-delivery systems, has announced a new business entity in Japan. As the second largest pharmaceutical single market, Japan is home to a number of leading global companies which offer a promising injectable pipeline. [image: Business Wire]

06-Oct-15 Kyushu University in Japan has collaborated with Jawaharlal Institute of Postgraduate Medical Education & Research (Jipmer) to provide telemedicine facilities in the field of surgical gastroenterology through video conferencing. Jipmer was designated a regional resource centre for telemedicine for South India in 2013. [image: ET Healthworld]